Life Science Reagents Market: Technological Advancements and High Prevalence of Chronic and Infectious Diseases to Boost Market
Life science reagents are an integral part of any clinical diagnostic laboratory and pharmaceutical & biotechnology industry. Technological advancements in molecular biology, life sciences, and biotechnology has brought about drastic changes in various fields such as medical diagnostics, drug discovery, personalized medicines, forensic sciences, and clinical research & development. Development in the areas of immunoassay technologies such as enzyme linked immune assay technology (ELISA), chemiluminescent immunosorbent assay (CLIA), and next generation sequencing (NGS) techniques are projected drive demand for immunoassay reagents during the forecast period. Moreover, molecular diagnostic techniques such as digital PCR, rtPCR, FISH, chromatography techniques, and flow cytometry techniques have witness high demand in the life science reagents market.
Technological advancements in cell and tissue culture have accelerated adoption of life science reagents in the areas of microbiology, antibiotics, and diagnostic testing. Clinical research organizations, diagnostic laboratories, and biotechnology players are engaged in the development of new diagnostic tests to address the unmet needs in the health care industry. Moreover, major manufacturers operating in the market are involved in continuous research & development activities to expand their product portfolio. In
Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1162
The report offers detailed segmentation of the global life science reagents market based on product type. In terms of product type, the immunoassay reagents segment is poised to account for leading share of the global market during the forecast period from 2018 to 2026. Immunoassays are widely used to detect concentration of antibodies, enzymes, hormones, etc. based on its ability to act as an antibody or antigen in a chemical reaction.
Wide applications of immunoassay reagents in the diagnosis of autoimmune disorders, cardiac disorders, fertility testing, diabetes testing, drugs of abuse testing, thyroid disorders, bone metabolism disorders, and inflammatory disorders have contributed to its leading share of the global market. Moreover, technological advancements in the immunoassay techniques such as chemiluminescence immunoassay (CLIA) technique and increasing adoption of CLIA technique in developed countries is projected to augment the segment during the forecast period.
For more information on this press release visit: http://www.sbwire.com/press-releases/life-science-reagents-market-technological-advancements-and-high-prevalence-of-chronic-and-infectious-diseases-to-boost-market-1103033.htm
Media Relations Contact
Telephone: 1-518-618-1030
Email: Click to Email
Web: https://www.transparencymarketresearch.com/
Clinical Decision Support System Market Is Driven by the Usage Based System Which Offered by the Various Knowledge-Based Systems
Global Health Insurance Market by Technology, Industry, Opportunity and Key Players Like: Allianz SE, Japan Post Holding Co., Ltd., Prudential Plc, Berkshire Hathaway
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News